Wall Street Analysts Think Phathom Pharmaceuticals (PHAT) Could Surge 87.21%: Read This Before Placing a Bet

Phathom Pharmaceuticals, Inc. (PHAT) closed the last trading session at $10.95, gaining 21% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $20.5 indicates an 87.2% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $8.02. While the lowest estimate of $5.00 indicates a 54.3% decline from the current price level, the most optimis ...